Myeloma and Related Diseases Registry (MRDR)

Helping clinicians and hospitals to provide the best possible care to people with multiple myeloma and related diseases.

More information

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
7348

Patients accrued

5230

Patients with multiple myeloma

59

Number of approved sites

684

M1000 Biobank participants

Latest news

New MRDR publication
06 Jun 2024

An MRDR paper investigating variation in immunoglobulin use and survival in myeloma has now been published!

Read more
MRDR reaches 7,000 patients!
22 Mar 2024

The MRDR reaches another milestone of recruiting more than 7,000 patients!

Read more
Rare Disease Day - Thursday 29th Feb!
23 Feb 2024

The MRDR supports Rare Disease Day 2024.

Read more
World Cancer Day - 4th February 2024
02 Feb 2024

The MRDR supports World Cancer Day.

Read more

Participating organisations